Erfordert Authentifizierung

Improving transfusion safety: the bookends of a century

   | 09. Nov. 2020

Zitieren

Landsteiner K.Zur kenntniss der antifermentativen, lytischen und agglutinirenden wirkungen des blut- serums und der lymphe.Zbl Bakt 1900;27:357.Search in Google Scholar

Landsteiner K. Ueber agglutinationserscheinungen normalen menschlichen blutes. Klin Wscher 1901;14:1132.Search in Google Scholar

Decastello A, Sturli A. Ueber die isoagglutinine im serum gesunder and kranker menschen. Munchen Med Wscher 1902;49:109.Search in Google Scholar

DeGowin EL, Hardin RC, Alsever JB. In: Blood trans- fusion.Philadelphia: WB Saunders Co., 1949:1.Search in Google Scholar

Landois L. Die transfusion des blutes. Leipzig, Germany: SCW Vogel, 1875.Search in Google Scholar

Wiener AS. Blood groups and transfusion. 3rd ed. Springfield, IL:C.C.Thomas, 1943:4.Search in Google Scholar

Blundell J.A successful case of transfusion. Lancet 1829;1:431.Search in Google Scholar

Rawstron RE. Preoperative hemoglobin levels. Anaes Intens Care 1976;4:175–3, 185.10.1177/0310057X7600400301Search in Google Scholar

Sherw o o d W. Triggers for the transfusion of red cells. In: Reid M, Nance SJ, eds. Red cell transfusion: a practical guide.Totowa, NJ:Humana, 1998;161–75.Search in Google Scholar

Ottenberg R.Transfusion and the question of intravascular agglutination.J Exper Med 1911; 13:425.10.1084/jem.13.4.425212487319867425Search in Google Scholar

Hustin A. Principe d’un nouvelle methode de transfusion muquese. J med de Brux 1914;72:104.Search in Google Scholar

Weil R. Sodium citrate in the transfusion of blood. JAMA 1915;64:425.10.1001/jama.1915.02570310045013Search in Google Scholar

Barker LF. Introduction. XVI annual American Red Cross scientific symposium: infection, immunity, blood transfusion. New York: Alan R. Liss, 1985: xix–xxv.Search in Google Scholar

DeGowin EL, Hardin RC, Al sever JB. In: Blood trans- fusion.Philadelphia:WB Saunders Co., 1949:234.15. Beeson PB. Jaundice occurring one to four months after transfusion of blood or plasma. JAMA 1943; 121:1332.10.1001/jama.1943.02840170016005Search in Google Scholar

Blumberg BS, Alter HJ, Visnich S.A new antigen in leukemic sera. JAMA 965;191:541.10.1001/jama.1965.0308007002500714239025Search in Google Scholar

Blumberg BS, Alter HJ, Riddell NM, et al. Multiple antigenic specificities of serum lipoproteins detected with sera of transfused patients. Vox Sang 1964;9:128.10.1111/j.1423-0410.1964.tb03672.x14147429Search in Google Scholar

Alter HJ, Holland PV, Purcell RH, et al.Post-transfusion hepatitis after exclusion of commercial and hepati- tis-B antigen positive donors. Ann Intern Med 1972;77:691–9.10.7326/0003-4819-77-5-6914628213Search in Google Scholar

Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV III) from patients with AIDS and at risk for AIDS. Science 1984;224:500.10.1126/science.62009366200936Search in Google Scholar

Barre-Sinoussi F, Chermann JC, Rey F, et al.Isolation of a T lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868.10.1126/science.61891836189183Search in Google Scholar

Montagnier L, Gruest J, Chamaret S, et al.Adaptation of lymphadenopathy-associated virus (LAV) to replication in EBV-transformed B lymphoblastoid celllines. Science 1984;225:63–6.10.1126/science.63286616328661Search in Google Scholar

Popovic M, Sarngad MG, Read E, et al.Detection, iso- lation and continuous production of cytopathic retroviruses (HTLV III) from patients with AIDS and pre-AIDS. Science 1984;224:497.10.1126/science.6200935Search in Google Scholar

Bruce-Chwatt LJ. Transfusion associated parasitic infections. XVI annual American Red Cross scientific symposium: infection, immunity, blood transfusion. New York: Alan R. Liss, 1985:101–25.Search in Google Scholar

Choo Q-L, Kuo G, Weiner AJ, et al.Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;224:359–62Search in Google Scholar

Kuo G, Choo Q-L, Alter HJ, et al.An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.Science 1989;244:362–4.10.1126/science.2496467Search in Google Scholar

Sherwood W. Personal observation.Search in Google Scholar

Turner TB, Diseker TH. Duration of infectivity of Treponema pallidum in citrated blood stored under conditions obtaining in blood banks. Bull Johns Hopkins Hosp 1941;68:269.Search in Google Scholar

Van der Sluis JJ, Onvlee PC, Kothe FCHA, et al. Transfusion syphilis, survival of Treponema pall i d um in donor blood.I.Report of an orienting study. Vox Sang 1984;47:197–204.10.1159/000466290Search in Google Scholar

Goldfield M. Some epidemiologic studies of transfusion-associated hepatitis. Infusiontherapie 1974; 8:645–9.Search in Google Scholar

Goldfield M, Bill J, Colosimo F. The control of transfusion-associated hepatitis. Viral Hepatitis (monograph) 1979.Search in Google Scholar

Tabor E, Goldfield M, Bl ack HC, et al. Hepatitis B e antigen in volunteer and paid blood donors. Transfusion 1980;20:192–8.10.1046/j.1537-2995.1980.20280169960.xSearch in Google Scholar

Henry JB. Blood policy and strategy: the American Blood Commission and the nation’s blood resource. Human Pathol 1980;11:1–3.10.1016/S0046-8177(80)80098-0Search in Google Scholar

Sherwood WC. Donor deferral registries.Transf Med Rev 1993;7:121–128.10.1016/S0887-7963(93)70131-5Search in Google Scholar

Sherwood WC.The significance of blood-borne viruses: blood banking and transfusion medicine. Virological safety aspects of plasma derivatives. Basel Karger 1993;81:25–33.Search in Google Scholar

Dodd RY. The risk of transfusion-transfusion infection (editorial). N Engl J Med 1992;327:419–21.10.1056/NEJM1992080632706101625717Search in Google Scholar

Selik RM, Ward JW, Buehler JW. Trends in transfusion- associated acquired immune deficiency syndrome in the United States, 1982 through 1991. Transfusion 1993;33:890–3.10.1046/j.1537-2995.1993.331194082377.x8259593Search in Google Scholar

Kroner BL, Rosenberg PS, Aledort LM, et al. HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978–1990. J Acquir Immun Def Syn 1994;7:279–86.Search in Google Scholar

Schreiber GB, Busch MP, Kleinman SH, et al.The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334:1685–90.10.1056/NEJM1996062733426018637512Search in Google Scholar

Etad BL.Viral infectivity of albumin and plasma protein fraction.Pharmacotherapy 1996;16:996–1001.Search in Google Scholar

Zuck TF. Blood safety decisions, 1982 to 1986: perceptions and misconceptions. Transfusion 1996; 36:928–31.10.1046/j.1537-2995.1996.361097017181.x8863782Search in Google Scholar

Roberts HR. The treatment of hemophilia: past tragedy and future promise. N Engl J Med 1989; 321:1188–90.10.1056/NEJM198910263211709Search in Google Scholar

Shikata T, Karasawa T, Abe K, et al.Incomplete inactivation of hepatitis B virus after heat treatment at 60°C for 10 hours.J Infect Dis 1978;138, 242–4.10.1093/infdis/138.2.242Search in Google Scholar

Prince A M, H o rowitz B, Brotman B, et al. Inactivation of hepatitis B and Hutchinson strain non-A, non-B hepatitis viruses by exposure to tween 80 and ether.Vox Sang 1984;46:36–43.10.1111/j.1423-0410.1984.tb00045.xSearch in Google Scholar

Horowitz B, Wiebe ME, Lippin A, et al. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid- enveloped viruses by tri(n-butyl)phosphate detergent combinations.Transfusion 1985;25:516–22.10.1046/j.1537-2995.1985.25686071422.xSearch in Google Scholar

Darr F. Taxonomy and classification of viruses. Plas+SD Update 1999;46:1–2.Search in Google Scholar

Lin L, Londe H, Hanson CV, et al.Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates.Blood 1993;82:292–7.10.1182/blood.V82.1.292.bloodjournal821292Search in Google Scholar

Lin L, Cook DN, Wiesehahn GP, et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.Transfusion 1997;37:423–35.10.1046/j.1537-2995.1997.37497265344.xSearch in Google Scholar

Dybus S, Aminoff D. Action of alpha-galactosidase from Cl os t ridium sporog en e s and coffee beans on blood group B antigen of erythrocytes.The effect on the viability of erythrocytes in circulation. Transfusion 1983;23:244–7.10.1046/j.1537-2995.1983.23383224905.xSearch in Google Scholar

Goldstein J. Conversion of ABO blood groups.Transf Med Rev 1989;3:206–12.10.1016/S0887-7963(89)70080-8Search in Google Scholar

Murad KL, Mahany KL. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood 1999; 93:2121–7.10.1182/blood.V93.6.2121.406a30_2121_2127Search in Google Scholar

Jeong ST, Byun SM. Decreased agglutinability of methoxy-polyethylene glycol attached red blood cells: significance as a blood substitute. Artif Cells Blood Substit Immobil Biotechnol 1996;24:503–11.10.3109/107311996091174428879424Search in Google Scholar

Hortin GL, Lok HT, Huang ST. Progress toward preparation of universal donor red cells. Artif Cells Blood Substit Immobil Biotechnol 1997;25:487–91.10.3109/10731199709118939Search in Google Scholar

Kruskall MS, AuBuchon JP. Making Landsteiner’s discovery superfluous: safety and economic implications of a universal group O red cell supply.Transfus Sci 1997:18:613–20.10.1016/S0955-3886(97)00061-1Search in Google Scholar

Murad KL, Gosselin EJ, Eaton JW. Stealth cells: prevention of major histocompatibility complex class II- mediated T-cell activation by cell surface modification. Blood 1999;94:2135–41.10.1182/blood.V94.6.2135Search in Google Scholar

Perkins HA, Payne R, Ferguson J. Nonhemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes. Vox Sang 1966; 11:578–600.10.1111/j.1423-0410.1966.tb04256.xSearch in Google Scholar

Bowden RA, Slichter SJ, Sayers M, et al.A comparison of fil tered leukocyte-reduced and cytomegalovi rus (CMV) blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3589–603.10.1182/blood.V86.9.3598.bloodjournal8693598Search in Google Scholar

Leukocyte reduction for the prevention of transfusion-transmitted cytomegalovirus (TT-CMV). Bethesda, MD:American Association of Blood Banks, 1997. Association bulletin 97–2.Search in Google Scholar

Yeager AS, Grumet FC, Hafleigh EB, et al.Prevention of transfusion acquired cytomegalovi rus infections in newborn infants. J Pediatr 1981;98:281–7.10.1016/S0022-3476(81)80662-2Search in Google Scholar

Brown KL, Stewart K, Ritchie DL, et al.Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat Med 1999;5:1308–12.10.1038/15264Search in Google Scholar

The trial to reduce alloimmunization to platelets (TRAP) study group. Leukocyte reduction and ultraviolet B radiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. New Engl J Med 1997;337:1861–9.10.1056/NEJM199712253372601Search in Google Scholar

Blumberg N, Heal JM. Blood transfusion immunomodulation: the silent epidemic. Arch Path Lab Med 1998;122:117–9.Search in Google Scholar

Murphy PJ, Connery C, Hicks GL, et al. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft opera- tions.JThorac Cardiovasc Surg 1992;104:1092–9.Search in Google Scholar

Tartter PL, Mohandas K, Azar P, et al. Randomized trial comparing packed red blood cell transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998;76:462–6.10.1016/S0002-9610(98)00245-1Search in Google Scholar

Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513–6.10.1002/bjs.18007906131611441Search in Google Scholar

Tartter PI, Mohandas K, Azar P, et al.Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998;176:462–6.10.1016/S0002-9610(98)00245-1Search in Google Scholar

Tartter PI.The association of perioperative blood transfusion with colorectal cancer recurren ce. Ann Surg 1992;216:633–8.10.1097/00000658-199212000-00004Search in Google Scholar

Chang TMS.Modified hemoglobin based blood substitutes: crosslinked, recombinant, and encapsulated hemoglobin.Vox Sang 1998;74(Suppl 2):233–41.10.1111/j.1423-0410.1998.tb05425.xSearch in Google Scholar

Rudolph AS, Rabinovici R, Feuerstein GZ. In: Red blood cell substitutes.New York:Marcel Dekker, Inc., 1997.Search in Google Scholar

Tsuchida E. In: Artificial red cells. New York: John Wiley and Sons, 1995.Search in Google Scholar

Chang TMS, Yu WP. Nanoencapsulation of hemoglobin and red blood cell enzymes based on nanotechnology and biodegradable polymer. In: Blood substitutes:principles, methods, products and clinical trials. Basel:Karger/Texas Landes 1998;Vol .2 : 216–31.Search in Google Scholar

Faithfull NS, Weers JG. Perfluorocarbon compounds. Vox Sang 1998;74(Suppl 2):243–8.10.1111/j.1423-0410.1998.tb05426.xSearch in Google Scholar

Sloviter HA, Kamimoto T. Erythrocyte substitute for perfusion of brain.Nature 1967;216:458–60.10.1038/216458a0Search in Google Scholar

Weers JG.A physicochemical evaluation of perfluorochemicals for oxygen transport applications. J Fluorine Chem 1993;64:73–93.10.1016/S0022-1139(00)80064-0Search in Google Scholar

Spence RK, McCoy S, Costabile J, et al. Fluosol DA-20 in the treatment of severe anemia: randomized controlled studies of 46 patients. Crit Care Med 1990;18:1227–30.10.1097/00003246-199011000-000081699704Search in Google Scholar

Spence RK, Norcross ED, Costabile J, et al.Perfluorocarbons as blood substitutes: the early years. Experience with Fluosol DA-20% in the 1980s. Artif Cells Blood Substit Immobil Biotechnol 1994;22:955–63.10.3109/107311994091387947849967Search in Google Scholar

Monk T, Winston R, Wahr J, et al.Perflubron emulsion is more effective than blood for transfusion trigger reversal. Anesth Analg 1998;86:S142.10.1097/00000539-199802001-00141Search in Google Scholar

Moreschi C. Neue Tatsachen uber die Blutkorper- chenagglutination.Zbl Bakt 1908;46:49.Search in Google Scholar

Coombs RRA, Mourant AE, Race RR.A new test for the detection of weak and ‘incomplete’rh agglutinins. Br J Exp Pathol 1945;26:255.Search in Google Scholar

Landsteiner K, Wiener AS.An agglutinable factor in human blood recognized by immune sera for Rhesus blood. Proc Soc Exper Biol & Med 1940;43:223.10.3181/00379727-43-11151Search in Google Scholar

Standards for blood banks and transfusion services. Bethesda, MD:American Association of Blood Banks, 1997. 18th ed. Para. 15.300: Computer crossmatch: 36–7.Search in Google Scholar

Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990; 30:583–90.10.1046/j.1537-2995.1990.30790385515.x2402771Search in Google Scholar

eISSN:
1930-3955
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, Laboratoriumsmedizin